Year None2023202220212020201920182017 Sep 21, 2023 Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences Aug 31, 2023 Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare Conference Aug 09, 2023 Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update Aug 02, 2023 Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth Conference May 10, 2023 Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update May 03, 2023 Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting May 02, 2023 Tenaya Therapeutics Receives FDA Fast Track Designation for TN-201 Apr 21, 2023 Tenaya Therapeutics to Participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit Mar 08, 2023 Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update Feb 07, 2023 Tenaya Therapeutics to Participate in Upcoming Investor Conferences Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 11
Sep 21, 2023 Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences
Aug 31, 2023 Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare Conference
Aug 09, 2023 Tenaya Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
Aug 02, 2023 Tenaya Therapeutics to Participate at the 43rd Annual Canaccord Genuity Growth Conference
May 10, 2023 Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
May 03, 2023 Tenaya Highlights Growing Capabilities in AAV Manufacturing, Capsid Engineering and Expansion into Gene Editing with Six Abstracts Accepted for Presentation at the ASGCT 26th Annual Meeting
Apr 21, 2023 Tenaya Therapeutics to Participate at Chardan's 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Mar 08, 2023 Tenaya Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
